Eye Patadine 0.2% Eye Drops (Olopatadine Hydrochloride)
Olopatadine Hydrochloride 2.22mg
Eye drops · Prescription medication
Genupharm Co., Ltd.
MFDS item code 201701559 · Approved 2017.03.31 · Insurance code 698003491
Relief of symptoms of allergic conjunctivitis
Used to relieve symptoms such as itching, redness, and tearing of the eyes caused by allergic conjunctivitis.
Instill 1 drop once daily.
This medication should not be used by patients who are allergic to the active ingredient or any component. Neurological symptoms such as headaches or altered taste and dizziness may occur during use. Care should be taken as symptoms such as punctate keratitis, keratitis, eye pain, dryness, swelling, itching, discharge, redness, and discomfort around the eyes may occur. Nasal dryness or symptoms of rhinitis may rarely occur, and symptoms of dry mouth may also be present. Contact dermatitis may develop on the skin, and fatigue may be felt. In clinical trials, approximately 10% of subjects experienced symptoms similar to a cold or pharyngitis, and symptoms such as weakness, back pain, cough, nausea, and sinusitis have also been reported. The phosphate component in this medication may rarely cause serious corneal damage such as corneal calcification, so caution is advised. If you are wearing contact lenses, you must wait at least 15 minutes after using this medication before putting in your lenses and it is best not to use it while wearing lenses. The benzalkonium chloride component in this medication can cause eye irritation or discoloration of lenses. Temporary blurriness of vision may occur after instillation, so care should be taken when driving or operating machinery. Pregnant women should carefully consider the effects on the fetus when using this medication, and nursing mothers should consult with a doctor regarding risks to their babies. It can be safely used in children over 3 years of age, and elderly patients can use it without special caution. In case of overdose, consult healthcare professionals immediately for appropriate observation and treatment. This medication is an eye drop only and should not be administered orally or intravenously. Take care not to allow the tip of the container to come into direct contact with the eye, and ensure the cap is securely closed after use. When using other eye drops, they should be administered with at least a 5-minute interval, and ointments should be used last. During storage, the cap should be securely closed to keep it clean when not in use.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light and should be stored in a special container that does not allow light in. Additionally, it is recommended to keep it in a cool place between 4 degrees and 25 degrees. Proper storage helps maintain the effect of the medication for a longer time.
A colorless to pale yellow liquid in an opaque white plastic bottle.
3mL/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Olopatadine Hydrochloride 2.22mg
Eye drops · Prescription medication
Genupharm Co., Ltd.
Olopatadine Hydrochloride 1.11mg
Eye drops · Prescription medication
Novartis Korea Co., Ltd.
Olopatadine Hydrochloride 5mg
Tablet · Prescription medication
Korea Kyowa Kirin Co., Ltd.
Olopatadine Hydrochloride 2.22mg
Eye drops · Prescription medication
Novartis Korea Co., Ltd.

Olopatadine Hydrochloride 5mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

Olopatadine Hydrochloride 5mg
Tablet · Prescription medication
Dongwha Pharmaceutical Co., Ltd.

Olopatadine Hydrochloride 5mg
Tablet · Prescription medication
Hanmi Pharmaceutical Co., Ltd.

Olopatadine Hydrochloride 5mg
Tablet · Prescription medication
International Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.